VIGNOZZI, LINDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.815
EU - Europa 11.594
AS - Asia 9.265
SA - Sud America 1.621
AF - Africa 230
OC - Oceania 189
Continente sconosciuto - Info sul continente non disponibili 2
Totale 40.716
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.622
RU - Federazione Russa 4.737
SG - Singapore 2.597
CN - Cina 2.536
IT - Italia 2.152
HK - Hong Kong 1.596
PL - Polonia 1.395
BR - Brasile 1.346
KR - Corea 1.027
IE - Irlanda 861
SE - Svezia 654
VN - Vietnam 485
DE - Germania 411
IN - India 306
FI - Finlandia 280
GB - Regno Unito 245
AU - Australia 188
CH - Svizzera 173
NL - Olanda 160
ID - Indonesia 139
FR - Francia 137
UA - Ucraina 134
JO - Giordania 133
AR - Argentina 118
CA - Canada 107
JP - Giappone 81
TR - Turchia 79
ES - Italia 63
ZA - Sudafrica 58
BD - Bangladesh 56
MX - Messico 56
AT - Austria 54
CI - Costa d'Avorio 53
EC - Ecuador 49
IQ - Iraq 42
MA - Marocco 29
IR - Iran 23
CL - Cile 22
PY - Paraguay 22
RO - Romania 22
CO - Colombia 21
LT - Lituania 21
BE - Belgio 19
PH - Filippine 19
PK - Pakistan 19
VE - Venezuela 18
DZ - Algeria 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
BJ - Benin 12
KE - Kenya 12
AL - Albania 11
AZ - Azerbaigian 11
EG - Egitto 11
PE - Perù 11
IL - Israele 10
KZ - Kazakistan 10
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
BG - Bulgaria 7
BY - Bielorussia 7
CZ - Repubblica Ceca 7
HN - Honduras 7
MD - Moldavia 7
NP - Nepal 7
SC - Seychelles 7
BH - Bahrain 6
NG - Nigeria 6
UG - Uganda 6
BO - Bolivia 5
GR - Grecia 5
HR - Croazia 5
KG - Kirghizistan 5
BA - Bosnia-Erzegovina 4
EE - Estonia 4
LA - Repubblica Popolare Democratica del Laos 4
PA - Panama 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
LB - Libano 3
MU - Mauritius 3
MY - Malesia 3
TH - Thailandia 3
AM - Armenia 2
BW - Botswana 2
GA - Gabon 2
LK - Sri Lanka 2
MK - Macedonia 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 40.688
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.760
Ashburn 1.822
Singapore 1.821
Fairfield 1.736
Warsaw 1.374
Hong Kong 1.367
Seoul 1.015
Chandler 925
Hefei 910
Dublin 855
Woodbridge 799
Seattle 755
Houston 743
Cambridge 638
Wilmington 570
Beijing 453
Altamura 369
Lawrence 366
Florence 339
Moscow 296
Buffalo 275
Los Angeles 275
Ann Arbor 255
Princeton 244
Jacksonville 212
Melbourne 174
Munich 168
Boston 164
Bern 158
Ho Chi Minh City 154
Dallas 149
New York 148
Mumbai 145
Rome 143
Kent 140
San Diego 130
Milan 118
Boardman 117
São Paulo 115
Medford 112
Shanghai 104
Jakarta 103
Hanoi 93
Paris 77
The Dalles 71
Clifton 65
Falls Church 62
London 60
Turku 59
Helsinki 56
Abidjan 53
Bengaluru 48
Lappeenranta 48
Dong Ket 46
Rio de Janeiro 46
Bologna 44
Redwood City 44
Chicago 43
Tokyo 43
Redondo Beach 41
Vienna 40
Chennai 39
Norwalk 37
Brooklyn 35
Belo Horizonte 32
Hillsboro 32
Okayama 30
Amsterdam 29
Naples 29
West Jordan 29
Frankfurt am Main 28
Guangzhou 28
Izmir 28
Johannesburg 28
Toronto 28
Curitiba 27
Barcelona 26
Council Bluffs 25
Haiphong 25
Dearborn 24
Porto Alegre 24
Yubileyny 24
Phoenix 23
Pune 23
Montreal 22
Andover 21
Denver 20
Turin 20
Brasília 19
Stockholm 19
Tianjin 19
Atlanta 18
Brussels 18
Quito 18
Poplar 17
Verona 17
Ankara 16
Campinas 16
Capelle aan den IJssel 16
Detroit 16
Totale 26.500
Salva come PNG Salva come JPEG
Nome #
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 505
Global Consensus Position Statement on the Use of Testosterone Therapy for Women 472
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 286
THE USE OF TADALAFIL TO TREAT LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW 283
Insulino-resistenza e fertilità nella donna con attenzione a sindrome dell'ovaio policistico (PCOS) e malattia epatica non alcoolica (NAFLD) 282
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlates with Sexual Dysfunctions 280
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 271
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons 266
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. 253
Androgens regulate Phosphodiesterase type 5 expression and functional activity in corpora cavernosa 250
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. 244
Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study 242
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. 239
A Randomized, Placebo-Controlled Study to Assess Safety andEfficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. 230
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 226
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. 216
Meta-analysis of metabolic syndrome and prostate cancer 215
Tumor Necrosis Factor α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons 212
5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature 209
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. 208
Acute effects on human sperm exposed in vitro to cadmium chloride and diisoutyl-phthalate 204
Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance 199
Anti-inflammatory effects of androgens in the human vagina 199
Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats 198
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. 197
The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol. 197
Estimate and needs of the transgender adult population: the SPoT study 194
Anti-inflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. 192
Insight on the intracrinology of menopause: androgen production within the human vagina 190
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. 189
Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men 188
Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? 187
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 185
Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span 183
Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis 181
Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. 181
Back to the Future: Is GnRHa treatment in transgender and gender diverse adolescents only an extended evaluation phase? 181
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. 180
Hypoactive sexual desire disorder in women: new possibilities to ensure better understanding, diagnosis, and response to treatment 178
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 178
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery 177
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. 175
Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data 174
Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction 173
Neural Correlates of Gender Face Perception in Transgender People 173
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. 172
Cardiometabolic Risk and Female Sexuality-Part II. Understanding (and Overcoming) Gender Differences: The Key Role of an Adequate Methodological Approach 172
A Novel Compound Heterozygous Mutation of HSD17B3 Gene Identified in a Patient With 46,XY Difference of Sexual Development 171
Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment 171
Does an increase in adipose tissue 'weight' affect male fertility? A systematic review and meta-analysis based on semen analysis performed using the WHO 2010 criteria. 171
Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. 171
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. 171
Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. 169
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. 169
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. 168
Cardiometabolic Risk and Female Sexuality-Part I. Risk Factors and Potential Pathophysiological Underpinnings for Female Vasculogenic Sexual Dysfunction Syndromes 168
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. 167
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? 167
Benign prostatic hyperplasia: a new metabolic disease? 167
Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study 167
Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study 167
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis 167
CHILDHOOD SEXUAL ABUSE MODERATES THE RELATIONSHIP BETWEEN SEXUAL FUNCTIONING AND EATING DISORDER PSYCHOPATHOLOGY IN ANOREXIA NERVOSA AND BULIMIA NERVOSA: A 1-YEAR-FOLLOW-UP STUDY. 164
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. 164
Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile 163
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. 161
Endocrine control of ejaculation 161
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. 161
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study 160
Reply: COVID-19: Semen impairment may not be related to the virus 160
Low Testosterone Levels Predict Clinical Adverse Outcomes in SARS-CoV-2 Pneumonia Patients 160
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits. 159
Internalized transphobia predicts worse longitudinal trend of body uneasiness in transgender persons treated with gender affirming hormone therapy: a 1-year follow-up study 158
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. 158
Sexual Health in Menopause 158
Anorectic and Bulimic Patients Suffer from Relevant Sexual Dysfunctions. 157
Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound. 157
Education degree predicts cardiovascular outcomes in men suffering from erectile dysfunction 156
Cryopreservation of Human Spermatozoa: Functional, Molecular and Clinical Aspects 156
Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective. 156
Treatment of Functional Hypogonadism Besides Pharmacological Substitution 155
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells (Erratum) 155
Novel methods to detect ROS in viable spermatozoa of native semen samples 155
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH 154
Obesity and hormonal contraception: an overview and a clinician's practical guide 154
Ghrelin as a possible biomarker and maintaining factor in patients with eating disorders reporting childhood traumatic experiences 154
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. 153
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model 153
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. 153
Beneficial effects of bile acid receptor agonists in pulmonary disease models. 153
Testosterone, cardiovascular disease and the metabolic syndrome. 151
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes. 151
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 150
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? 150
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. 149
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. 149
Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high-fat diet experimental rabbit animal model 149
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men 149
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. 149
Male reproductive system inflammation after healing from coronavirus disease 2019 149
Totale 18.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.501 0 0 0 0 0 257 139 184 246 354 163 158
2021/20222.029 85 205 301 61 55 77 74 235 96 82 316 442
2022/20234.444 387 995 168 268 290 711 523 224 392 131 122 233
2023/20242.636 72 178 366 132 202 237 181 642 103 245 181 97
2024/202513.734 511 1.320 891 2.008 3.580 1.393 414 786 707 479 911 734
2025/20269.933 1.836 2.481 1.949 1.705 1.907 55 0 0 0 0 0 0
Totale 41.441